These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 32312419

  • 1. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
    Klein MA.
    Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
    [Abstract] [Full Text] [Related]

  • 2. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R.
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [Abstract] [Full Text] [Related]

  • 3. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R.
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [Abstract] [Full Text] [Related]

  • 4. Cyclins and related kinases in cancer cells.
    Malumbres M.
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle regulators in cancer cell metabolism.
    Leal-Esteban LC, Fajas L.
    Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165715. PubMed ID: 32035102
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.
    Liao Y, Feng Y, Shen J, Hornicek FJ, Duan Z.
    Cancer Metastasis Rev; 2016 Jun 01; 35(2):151-63. PubMed ID: 26669603
    [Abstract] [Full Text] [Related]

  • 8. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D, Ortega S.
    Front Biosci; 2006 Jan 01; 11():1164-88. PubMed ID: 16146805
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
    Chou J, Quigley DA, Robinson TM, Feng FY, Ashworth A.
    Cancer Discov; 2020 Mar 01; 10(3):351-370. PubMed ID: 32071145
    [Abstract] [Full Text] [Related]

  • 11. New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy.
    Bury M, Le Calvé B, Ferbeyre G, Blank V, Lessard F.
    Trends Cell Biol; 2021 May 01; 31(5):331-344. PubMed ID: 33676803
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular systems biology of Sic1 in yeast cell cycle regulation through multiscale modeling.
    Barberis M.
    Adv Exp Med Biol; 2012 May 01; 736():135-67. PubMed ID: 22161326
    [Abstract] [Full Text] [Related]

  • 14. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
    Lee YM, Sicinski P.
    Cell Cycle; 2006 Sep 01; 5(18):2110-4. PubMed ID: 16969111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC, Huang WR, Liao TL, Chi PI, Nielsen BL, Liu JH, Liu HJ.
    J Biol Chem; 2018 Aug 10; 293(32):12542-12562. PubMed ID: 29907572
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.